Adagene was co-founded by two serial entrepreneurs to power antibody discovery. Its aim is to become the leading player in antibody discovery and engineering. It has developed a proprietary dynamic precision library (DPL) and is showcasing the power of the library with a unique pipeline of innovative antibody therapeutics that is advancing into clinical trials. Adagene previously has raised three series of financing with over $86 million. Investors include F-Prime Capital (formerly Fidelity Biosciences), Eight Roads Ventures China (formerly Fidelity Growth Partners Asia), 6 Dimensions Capital, GP Healthcare Capital, Sequoia China, and New World TMT.adagene.com
China, Nuevo Leon, Mexico, 4F Crescent Rd, Greenbelt, MD, USA, Massachusetts, USA, Suzhou, Jiangsu, China
Founded in 2011
Inaccurate data? Flag it here.
Open jobs at Adagene